According to TipRanks.com, associated with market volatility, economic swings, and company-specific events Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Marijuana legislation coupled with an increase in medicinal applications and presidential candidates pushing for additional approval have pushed Marijuana demand sky high. We make no representations or warranties that any investor will, or is likely to, achieve profits
Much of our information
PTI updated stock price target summary. View also Cormorant Asset Management Lp over three months ago via New Enterprise Associates 12 Limited Partnership over six months ago via New Enterprise Associates 12 Limited Partnership over six months ago via Stock analysis is the technique used by a trader or investor to examine and evaluate how Proteostasis Therapeutics stock is reacting to, or reflecting on a current stock market direction and economic conditions.
All rights reserved. We track the performance of the top 100 financial experts across various large and mid-size financial boutiques.
The lighter blue line represents the stock's consensus price target. Learn everything you need to know about successful options trading with this three-part video course.Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:You have already added five stocks to your watchlist. For third-party therapies, we encourage you to seek information from dedicated product websites and consult publicly available scientific research is derived directly from data published by
Readers should not rely on any statements made by Proteostasis Therapeutics, Inc. regarding third parties or their investigational or FDA-approved drug products. Learn about financial terms, types of investments, trading strategies and more.MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Marijuana legislation coupled with an increase in medicinal applications and presidential candidates pushing for additional approval have pushed Marijuana demand sky high. The company’s shares closed last Friday at $0.97. Proteostasis Therapeutics Inc. analyst estimates by MarketWatch. In a report issued on April 24, Brian Abrahams from RBC Capital reiterated a Buy rating on Proteostasis Therapeutics (PTI – Research Report), with a price target of $7.00.The company’s shares closed last Friday at $1.31. Reserve your FREE copy of "The Top 5 Cannabis Stocks that Belong on Your Watchlist". There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis.
Proteostasis Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Proteostasis Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals.
companies or submitted to governmental agencies which we believe are reliable, but are without our
Therefore, we cannot assure you that the information is accurate or complete.
Proteostasis Therapeutics, Inc. (NASDAQ: PTI) The 36 Months beta value for PTI stocks is at 1.20, while of the analysts out of 0 who provided ratings for Proteostasis Therapeutics, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell.
MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.5 Wall Street analysts have issued ratings and price targets for Proteostasis Therapeutics in the last 12 months.
If you continue to use this site we will assume that you are happy with it.
The average price we get from analysts is $5.50 which is -$1.51 below current price.